Beijing Sunheal Technology Co., Ltd. established in Oct 2003,focus on pharmaceutical policy and consultancy services. It has successfully provided consultancy services for six large-scale domestic pharma groups, more than 200 pharmaceutical enterprises and has 3 consultants employed as visiting experts by Training Center of SFDA,. during the past few years, it has published a series of pharmaceutical publications having self-owned intellectual property. Sichuan Sunheal Pharmaceutical Co., Ltd, established in Aug 2006, is one of subsidiaries of Beijing Sunheal Technology Co., Ltd. It is a new Hi-Tech pharma company mainly focused on pharmaceutical R&D and marketing.

At present we have a outstanding team which is highly efficient, professional, powerful and have rich experience in R&D and marketing. Our senior executives have experience worked in domestic large-scale pharma enterprises and joint-venture companies. Our academic leaders have Master degree or Ph.D degree and more than 70% of our employees are undergraduates. Depending on professional capabilities in project establishment, clinical study and legal registration affairs, our company have enough strength in product development and have launched a series of competitive catagory products. We have built a professional marketing team, organized a sales network across mainland China. We gained a sizable sales revenues since the implementation of individual business model according to product characteristic and maximizing product potential. In order to make sure properly the results of our strategy and the efficiency of the operation, we designed a set of effective management systems, including strategy planning, budget auditing driving and managing reports, forming a professional management mechanism.

We have been adhering to company culture of "Sunny bright, Value, Innovative, Highly efficient" and insist on innovation-style development strategy. We always aim to develop high quality medical products to serve people’s health, promote industrial progress and pay back to the society.

Based on more understanding of China market and the advantage of resource integration, we can take business opportunities in time in the pharma market, which is one of most rapid growth worldwide, and become ideal cooperation partner with international pharmaceutical enterprises intending to enter China market.